Connick JH - Search Results

1

NMDA-receptor-independent effects of low magnesium: involvement of adenosine.

Stone TW, Connick JH, Bartrup JT. Stone TW, et al. Among authors: connick jh. Brain Res. 1990 Feb 5;508(2):333-6. doi: 10.1016/0006-8993(90)90419-c. Brain Res. 1990. PMID: 2155041

2

Changes in neurotransmitter sensitivity in the mouse neocortical slice following propranolol and theophylline administration.

Mally J, Connick JH, Stone TW. Mally J, et al. Among authors: connick jh. Br J Pharmacol. 1991 Mar;102(3):711-7. doi: 10.1111/j.1476-5381.1991.tb12238.x. Br J Pharmacol. 1991. PMID: 1364843 Free PMC article.

3

Chronic benzodiazepine treatment and cortical responses to adenosine and GABA.

Mally J, Connick JH, Stone TW. Mally J, et al. Among authors: connick jh. Brain Res. 1990 Oct 22;530(2):353-7. doi: 10.1016/0006-8993(90)91311-4. Brain Res. 1990. PMID: 1979931

4

Theophylline down-regulates adenosine receptor function.

Mally J, Connick JH, Stone TW. Mally J, et al. Among authors: connick jh. Brain Res. 1990 Feb 12;509(1):141-4. doi: 10.1016/0006-8993(90)90321-2. Brain Res. 1990. PMID: 2407315

5

Effect of changing extracellular levels of magnesium on spontaneous activity and glutamate release in the mouse neocortical slice.

Smith DA, Connick JH, Stone TW. Smith DA, et al. Among authors: connick jh. Br J Pharmacol. 1989 Jun;97(2):475-82. doi: 10.1111/j.1476-5381.1989.tb11975.x. Br J Pharmacol. 1989. PMID: 2758226 Free PMC article.

6

The sigma ligand 1,3-di-o-tolylguanidine depresses amino acid-induced excitation non-selectively in rat brain.

Connick JH, Addae JI, Nicholson CD, Stone TW. Connick JH, et al. Eur J Pharmacol. 1992 Apr 22;214(2-3):169-73. doi: 10.1016/0014-2999(92)90115-k. Eur J Pharmacol. 1992. PMID: 1325354

7

Interactions of adenosine and magnesium on neuronal excitability and transmitter sensitivity in the hippocampal slice.

Stone TW, Bartrup JT, Brooks PA, Connick JH, Smith DA. Stone TW, et al. Among authors: connick jh. Epilepsy Res Suppl. 1992;8:237-42. doi: 10.1016/b978-0-444-89710-7.50036-7. Epilepsy Res Suppl. 1992. PMID: 1329815 No abstract available.

8

Nicotinylalanine increases cerebral kynurenic acid content and has anticonvulsant activity.

Connick JH, Heywood GC, Sills GJ, Thompson GG, Brodie MJ, Stone TW. Connick JH, et al. Gen Pharmacol. 1992 Mar;23(2):235-9. doi: 10.1016/0306-3623(92)90017-e. Gen Pharmacol. 1992. PMID: 1639238

9

Effects of quinolinic and kynurenic acids on central neurons.

Stone TW, Connick JH. Stone TW, et al. Among authors: connick jh. Adv Exp Med Biol. 1991;294:329-36. doi: 10.1007/978-1-4684-5952-4_30. Adv Exp Med Biol. 1991. PMID: 1663314 Review. No abstract available.

10

Quinolinic acid neurotoxicity: protection by intracerebral phenylisopropyladenosine (PIA) and potentiation by hypotension.

Connick JH, Stone TW. Connick JH, et al. Neurosci Lett. 1989 Jun 19;101(2):191-6. doi: 10.1016/0304-3940(89)90529-6. Neurosci Lett. 1989. PMID: 2771165

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters